E3 PreliminaryPreliminaryPEM ✓MechanisticPeer-reviewedMachine draft
Suggested pathology of systemic exertion intolerance disease: Impairment of the E3 subunit or crossover of swinging arms of the E2 subunit of the pyruvate dehydrogenase complex decreases regeneration of cofactor dihydrolipoic acid of the E2 subunit.
Bohne, Victoria J Berdikova, Bohne, Øyvind · Medical hypotheses · 2019 · DOI
Quick Summary
This paper proposes that ME/CFS might result from a problem in how the body converts fuel into energy, specifically involving a protein complex called the pyruvate dehydrogenase complex. The researchers suggest that when this complex isn't working properly, it causes lactate (a byproduct of metabolism) to build up suddenly in the body, which could explain the exhaustion and post-exertional malaise (worsening after activity) that patients experience. They propose that the body isn't efficiently recycling important molecules needed for energy production, leading to low energy and fatigue.
Why It Matters
Understanding the cellular mechanisms behind ME/CFS is crucial for developing targeted treatments, as current therapies remain ineffective for most patients. If PDC dysfunction is confirmed as central to disease pathology, it could guide development of novel interventions targeting lactate metabolism and energy production. This hypothesis also offers a potential explanation for why standard fatigue treatments fail and why activity can worsen symptoms so dramatically.
Observed Findings
- No empirical findings are presented; this is a theoretical mechanistic proposal rather than an experimental study with data.
Inferred Conclusions
- Impaired DHLA regeneration in the pyruvate dehydrogenase complex may underlie ME/CFS pathogenesis through chronic instantaneous hyperlactataemia
- Instantaneous lactate elevation could explain post-exertional malaise symptoms
- Reduced ATP production from decreased pyruvate throughput may account for fatigue severity
- The condition may be characterized as a functional lipoic acid deficiency with metabolic consequences
Remaining Questions
- Do ME/CFS patients actually show the predicted patterns of instantaneous lactate elevation and DHLA/LA ratio dysregulation during and after exertion?
- Which specific alterations to the E3 subunit or E2 swinging arms occur in ME/CFS, and how prevalent are they across patients?
- Would treatments targeting lactate metabolism, DHLA regeneration, or lipoic acid supplementation improve post-exertional malaise or fatigue in clinical trials?
- How do the proposed instantaneous metabolic fluctuations correlate with symptom timing and severity in individual patients?
What This Study Does Not Prove
This is a theoretical hypothesis paper with no experimental data, clinical measurements, or patient samples presented—it does not prove that PDC dysfunction causes ME/CFS in humans. The proposed mechanism connecting lactate fluctuations to symptoms is speculative and requires empirical validation through controlled studies. The paper does not establish whether any observed lactate elevations are a cause or consequence of the disease process.
Tags
Symptom:Post-Exertional MalaiseFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:Exploratory Only